The company
State Street SPDR S&P Biotech ETF
XBI · NYSE Arca · fund
XBI stood above a rising 150-day average in 51 of the last 52 weekly readings, and has been out of that trend for the last 1 week. It is 0.5% below that average now.
Statistics
- Rotation
- not in the set
- Weeks in an uptrend
- out for 1
- Officials’ trades on record
- 14
- Institutions holding
- 891 (+116)
In the rotation
Each square a week: lit when it closed above a rising 150-day average. 51 of 52 weeks.
Money in and out
Open-market buys above the line and sales below, in dollars.
Congress and officials
14 disclosed lines: House 4, Senate 10, executive 0; 5 people.
| Who | Did | Amount | Traded |
|---|---|---|---|
| Tommy Tuberville Senate: U.S. Senate eFDSenator | boughtjoint | $1k–$15k | 8 May 2024filed 5 Aug 2026 |
| Tommy Tuberville Senate: U.S. Senate eFDSenator | boughtjoint | $1k–$15k | 8 May 2024filed 5 Aug 2026 |
| Tommy Tuberville Senate: U.S. Senate eFDSenator | boughtjoint | $1k–$15k | 8 May 2024filed 14 Jun 2024 |
| Tommy Tuberville Senate: U.S. Senate eFDSenator | boughtjoint | $1k–$15k | 8 May 2024filed 14 Jun 2024 |
| David P. Joyce House: U.S. House ClerkOH14 | sold | $15k–$50k | 30 Jun 2023filed 6 Aug 2024 |
| James M. Inhofe Senate: U.S. Senate eFDSenator | sold | $15k–$50k | 30 Sep 2019filed 18 Oct 2019 |
| James M. Inhofe Senate: U.S. Senate eFDSenator | bought | $15k–$50k | 31 Dec 2018filed 9 Jan 2019 |
| Jack Reed Senate: U.S. Senate eFDSenator | sold part ofjoint | $1k–$15k | 9 Mar 2018filed 12 Mar 2018 |
| Jack Reed Senate: U.S. Senate eFDSenator | boughtjoint | $1k–$15k | 19 Jun 2017filed 20 Jun 2017 |
| Jack Reed Senate: U.S. Senate eFDSenator | bought | $1k–$15k | 6 Mar 2017filed 7 Mar 2017 |
| Jack Reed Senate: U.S. Senate eFDSenator | boughtjoint | $1k–$15k | 6 Mar 2017filed 7 Mar 2017 |
| David P. Joyce House: U.S. House ClerkOH14 | bought | $1k–$15k | 23 Feb 2017filed 8 May 2019 |
Insiders
No open-market buy or sale by its insiders on record.
Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.
Institutions
Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.
| Manager | Shares | Change |
|---|---|---|
| BNP PARIBAS FINANCIAL MARKETSreduced · filed 13 Aug 2026 | 16,777,726$2.7B | -4,378,146−20.7% |
| GOLDMAN SACHS GROUP INCadded · filed 14 Aug 2026 | 15,111,803$2.4B | +1,392,459+10.1% |
| CITIGROUP INCadded · filed 3 Aug 2026 | 11,612,884$1.8B | +949,480+8.9% |
| MORGAN STANLEYreduced · filed 13 Aug 2026 | 10,834,146$1.7B | -1,497,407−12.1% |
| BANK OF AMERICA CORPreduced · filed 14 Aug 2026 | 10,566,963$1.7B | -3,951,064−27.2% |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUNDreduced · filed 13 Aug 2026 | 9,341,500$1.5B | -404,000−4.1% |
| WELLS FARGO & COMPANYadded · filed 14 Aug 2026 | 3,504,082$554.5M | +757,873+27.6% |
| UBS Group AGreduced · filed 13 Aug 2026 | 3,308,923$523.6M | -237,727−6.7% |
| BARCLAYS PLCreduced · filed 14 Aug 2026 | 2,817,943$445.9M | -16,217−0.6% |
| Jefferies Financial Group Inc.reduced · filed 17 Aug 2026 | 2,140,001$338.7M | -174,719−7.5% |
News
No headline names it lately.
Everyone who traded it
Same industry
No other stock in its industry this week.
Government contracts
No federal award is tied to it.
From its SEC filings
No ratio computed from its SEC filings yet.
Analyst forecasts
No analyst forecasts yet.